CELG RT — Bristol-Myers Squibb Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapContrarian

Annual balance sheet for Bristol-Myers Squibb Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	15,831	17,221	9,253	12,280	10,859
Net Total Accounts Receivable
Net Total Receivables	8,501	12,516	13,937	15,264	14,424
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	30,192	33,262	27,273	31,770	29,780
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6,745	6,968	7,475	8,036	8,360
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	118,481	109,314	96,820	95,159	92,603
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	19,080	21,868	21,890	22,262	23,774
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	80,659	73,368	65,759	65,729	76,268
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	37,822	35,946	31,061	29,430	16,335
Total Liabilities & Shareholders' Equity	118,481	109,314	96,820	95,159	92,603
Total Common Shares Outstanding